All Updates

All Updates

icon
Filter
M&A
Labcorp acquires select assets from Invitae to expand specialty testing capabilities
Precision Medicine
Aug 5, 2024
This week:
Management news
6K Additive awarded project to develop C-103 powder for additive manufacturing
Additive Manufacturing
Sep 27, 2024
Partnerships
WAAM3D partners with Innovative Space Carrier, Cranfield University, and Aichi Sangyo for space transport development
Additive Manufacturing
Sep 19, 2024
Product updates
Akselos introduces software for FPSO monitoring
Digital Twin
Yesterday
Funding
Operant AI raises USD 10 million in Series A funding to boost runtime protection
Next-gen Cybersecurity
Yesterday
Funding
Aembit raises USD 25 million in Series A funding to advance IAM solutions
Identity & Access Management
Yesterday
Product updates
Saviynt launches Intelligence Suite for identity security
Identity & Access Management
Yesterday
Partnerships
Geographic expansion
FarmWise partners with RDO Equipment Co. to expand AI-powered weeding technology for vegetable growers
Smart Farming
Yesterday
Management news
Alberta Food Security Inc. receives USD 5 million order for indoor farming technology
Vertical Farming
Yesterday
Partnerships
AutoStore enhances microfulfilment offering with new grid capabilities and multi-temperature solution
Logistics Tech
Yesterday
Product updates
OpenAI launches o1, a self-fact-checking AI model
Generative AI Applications
Yesterday
Precision Medicine

Precision Medicine

Aug 5, 2024

Labcorp acquires select assets from Invitae to expand specialty testing capabilities

M&A

  • Labcorp has acquired select assets of Invitae, a leading medical genetics company.

  • The acquisition expands Labcorp's specialty testing capabilities and the company's ability to utilize genetic data to improve clinical trials and treatment regimens in oncology and select rare diseases. By integrating Invitae's genetic testing technology with Labcorp's specialty testing capabilities, the company will offer a complete set of insights for each patient, from testing and diagnosis to treatment.

  • Analyst QuickTime: In April 2024 , Labcorp was selected as the winning bidder for select assets of Invitae for USD 239 million. This acquisition was expected to generate annual revenue of ~USD 275 million–300 million for Labcorp, most of which will come from specialty testing.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.